Gilberto J. Aquino

Gilberto J. Aquino

Auto-generated profile, based on publicly available information

Gilberto J. Aquino

Medical University of South Carolina, Department of Radiology and Radiological Science, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2023 in Radiology
Verified
Journal Article
Closed access
GAGilberto J. Aquino
Gilberto J. Aquino
JDJim O Doherty
Jim O Doherty
USU. Joseph Schoepf
U. Joseph Schoepf
BEBenjamin Ellison
Benjamin Ellison
JBJordan Byrne
Jordan Byrne
Tilman EmrichTilman Emrich
Tilman Emrich
Background Photon-counting detector (PCD) CT provides comprehensive spectral data with every acquisition, but studies evaluating myocardial extracellular volume (ECV) quantification with use of PCD CT compared with an MRI reference remain lacking. Purpose To compare ECV quantification for myocardial tissue characterization between a first-generation PCD CT system and cardiac MRI. Materials and Methods In this single-center prospective study, adults without contraindication to iodine-based contrast media underwent same-day cardiac PCD CT and MRI with native and postcontrast T1 mapping and late gadolinium enhancement for various clinical indications for cardiac MRI (the reference standard) between July 2021 and January 2022. Global and midventricular ECV were assessed with use of three methods: single-energy PCD CT, dual-energy PCD CT, and MRI T1 mapping. Quantitative comparisons among all techniques were performed. Correlation and reliability between different methods of ECV quantification were assessed with use of the Pearson correlation coefficient (r) and the intraclass correlation coefficient. Results The final sample included 29 study participants (mean age ± SD, 54 years ± 17; 15 men). There was a strong correlation of ECV between dual- and single-energy PCD CT (r = 0.91, P < .001). Radiation dose was 40% lower with dual-energy versus single-energy PCD CT (volume CT dose index, 10.1 mGy vs 16.8 mGy, respectively; P < .001). In comparison with MRI, dual-energy PCD CT showed strong correlation (r = 0.82 and 0.91, both P < .001) and good to excellent reliability (intraclass correlation coefficients, 0.81 and 0.90) for midventricular and global ECV quantification, but it overestimated ECV by approximately 2%. Single-energy PCD CT showed similar relationship with MRI but underestimated ECV by 3%. Conclusion Myocardial tissue characterization with photon-counting detector CT-based quantitative extracellular volume analysis showed a strong correlation to MRI. © RSNA, 2023 Supplemental material is available for this article.

1 January 2022 in Radiology
Verified
Journal Article
Closed access
GAGilberto J. Aquino
Gilberto J. Aquino
AAAndres F. Abadia
Andres F. Abadia
USU. Joseph Schoepf
U. Joseph Schoepf
Tilman EmrichTilman Emrich
Tilman Emrich
BYBasel Yacoub
Basel Yacoub
JBJeremy R. Burt
Jeremy R. Burt
CT fractional flow reserve was associated with major adverse cardiac events in candidates for transcatheter aortic valve replacement and improved the predictive value of coronary CT angiography ass... Background The role of CT angiography–derived fractional flow reserve (CT-FFR) in pre–transcatheter aortic valve replacement (TAVR) assessment is uncertain. Purpose To evaluate the predictive value...

15 January 2022 in European Journal of Radiology
Verified
Journal Article
Closed access
VBVerena Brandt
Verena Brandt
RBRaffi Bekeredjian
Raffi Bekeredjian
USU. Joseph Schoepf
U. Joseph Schoepf
AVAkos Varga-Szemes
Akos Varga-Szemes
Tilman EmrichTilman Emrich
Tilman Emrich
Christian TescheChristian Tesche
Christian Tesche

1 May 2022 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
GAGilberto J. Aquino
Gilberto J. Aquino
JCJordan Chamberlin
Jordan Chamberlin
MMMegan Mercer
Megan Mercer
MKMadison Kocher
Madison Kocher
IKIsmail Kabakus
Ismail Kabakus
JBJeremy R. Burt
Jeremy R. Burt

28 April 2022 in Journal of Thoracic Imaging
Verified
Journal Article
Closed access
AAAndres F. Abadia
Andres F. Abadia
GAGilberto J. Aquino
Gilberto J. Aquino
USU. Joseph Schoepf
U. Joseph Schoepf
MWMichael Wels
Michael Wels
BSBernhard Schmidt
Bernhard Schmidt
Tilman EmrichTilman Emrich
Tilman Emrich
Objectives: We aimed to validate and test a prototype algorithm for automated dual-energy computed tomography (DECT)-based myocardial extracellular volume (ECV) assessment in patients with various cardiomyopathies. Methods: This retrospective study included healthy subjects (n=9; 61±10 y) and patients with cardiomyopathy (n=109, including a validation cohort n=60; 68±9 y; and a test cohort n=49; 69±11 y), who had previously undergone cardiac DECT. Myocardial ECV was calculated using a prototype-based fully automated algorithm and compared with manual assessment. Receiver-operating characteristic analysis was performed to test the algorithm’s ability to distinguish healthy subjects and patients with cardiomyopathy. Results: The fully automated method led to a significant reduction of postprocessing time compared with manual assessment (2.2±0.4 min and 9.4±0.7 min, respectively, P<0.001). There was no significant difference in ECV between the automated and manual methods (P=0.088). The automated method showed moderate correlation and agreement with the manual technique (r=0.68, intraclass correlation coefficient=0.66). ECV was significantly higher in patients with cardiomyopathy compared with healthy subjects, regardless of the method used (P<0.001). In the test cohort, the automated method yielded an area under the curve of 0.98 for identifying patients with cardiomyopathies. Conclusion: Automated ECV estimation based on DECT showed moderate agreement with the manual method and matched with previously reported ECV values for healthy volunteers and patients with cardiomyopathy. The automatically derived ECV demonstrated an excellent diagnostic performance to discriminate between healthy and diseased myocardium, suggesting that it could be an effective initial screening tool while significantly reducing the time of assessment.

15 February 2022 in Heliyon
Verified
Journal Article
Open access
MKMadison R. Kocher
Madison R. Kocher
JCJordan Chamberlin
Jordan Chamberlin
JWJeffrey Waltz
Jeffrey Waltz
MSMadalyn Snoddy
Madalyn Snoddy
NSNatalie Stringer
Natalie Stringer
JBJeremy R. Burt
Jeremy R. Burt
Determination of the total number and size of all pulmonary metastases on chest CT is time-consuming and as such has been understudied as an independent metric for disease assessment. A novel artificial intelligence (AI) model may allow for automated detection, size determination, and quantification of the number of pulmonary metastases on chest CT. To investigate the utility of a novel AI program applied to initial staging chest CT in breast cancer patients in risk assessment of mortality and survival. Retrospective imaging data from a cohort of 226 subjects with breast cancer was assessed by the novel AI program and the results validated by blinded readers. Mean clinical follow-up was 2.5 years for outcomes including cancer-related death and development of extrapulmonary metastatic disease. AI measurements including total number of pulmonary metastases and maximum nodule size were assessed by Cox-proportional hazard modeling and adjusted survival. 752 lung nodules were identified by the AI program, 689 of which were identified in 168 subjects having confirmed lung metastases (Lmet+) and 63 were identified in 58 subjects without confirmed lung metastases (Lmet-). When compared to the reader assessment, AI had a per-patient sensitivity, specificity, PPV and NPV of 0.952, 0.639, 0.878, and 0.830. Mortality in the Lmet + group was four times greater compared to the Lmet-group (p = 0.002). In a multivariate analysis, total lung nodule count by AI had a high correlation with overall mortality (OR 1.11 (range 1.07–1.15), p < 0.001) with an AUC of 0.811 (R2 = 0.226, p < 0.0001). When total lung nodule count and maximum nodule diameter were combined there was an AUC of 0.826 (R2 = 0.243, p < 0.001). Automated AI-based detection of lung metastases in breast cancer patients at initial staging chest CT performed well at identifying pulmonary metastases and demonstrated strong correlation between the total number and maximum size of lung metastases with future mortality. As a component of precision medicine, AI-based measurements at the time of initial staging may improve prediction of which breast cancer patients will have negative future outcomes.